FIELD: pharmaceutics.
SUBSTANCE: present invention relates to pharmaceutical compositions containing at least one GLP-1 agonist and propylene glycol, and also relates to methods for reducing clogging of injection devices with a peptide composition and reducing the formation of deposits in production equipment during the manufacture of a peptide composition.
EFFECT: reducing the formation of deposits in production equipment.
9 cl, 7 dwg. 15 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE COMPOSITION CONTAINING PROPYLENE GLYCOL OPTIMAL FOR MANUFACTURING AND APPLICATION IN INJECTION DEVICES | 2004 |
|
RU2421238C2 |
| STABLE PREPARATIONS OF INSULIN PEPTIDES | 2005 |
|
RU2413530C2 |
| METHOD OF PEPTIDE ACIDIFYING | 2003 |
|
RU2345062C2 |
| STABILISED PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE | 2004 |
|
RU2421236C2 |
| METHOD OF CONJUGATING PEPTIDES, MEDIATED BY TRANSGLUTAMINASE | 2005 |
|
RU2385879C2 |
| NOVEL ANALOGUES OF GLUCAGON-LIKE PEPTIDE, COMPOSITION AND METHOD OF USE | 2010 |
|
RU2557301C2 |
| GLP-1 ANALOGS | 1999 |
|
RU2288232C9 |
| NOVEL GLUCAGON ANALOGUES | 2011 |
|
RU2559320C2 |
| REGENERATION OF CHROMATOGRAPHIC STATIONARY PHASE | 2004 |
|
RU2350945C2 |
| STABLE NON-AQUEOUS PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2472492C2 |
